photo of

Details

Role Team Leader / Dir. Cord Blood Bank
Research area Stem Cell Medicine

Contact

Available for student supervision
Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Children's Research Institute. Her current research interest is aimed at extending the use of cord blood for cellular therapies, particularly through clinical grade cord blood derived iPSCs and cord blood for cardiac repair..

Ngaire serves as Chair of the AusCord network of public cord blood banks. She is Vice President of the international Board of Directors for the Foundation for the Accreditation of Cellular Therapies (FACT), is a FACT inspector and serves on various FACT committees. Other board and executive appointments include Non-Executive Director on the Board of the National Stem Cell Foundation of Australia, Chair of the Australian Sickle Cell Advocacy Inc, and a member of the Board of the International Society for Cell & Gene Therapy (ISCT). Ngaire serves on the TGA Advisory Committee on Biologicals and the MCRI Institutional Biosafety Committee.

Ngaire has devoted her career to providing improved therapies for the treatment of cancer, leukaemia and other disorders, and is passionate about the therapeutic application of cellular therapies.
Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Children's Research Institute. Her current research interest is aimed at extending the use of cord...
Associate Professor Ngaire Elwood is the Director of the BMDI Cord Blood Bank and Head of the Cord Blood Stem Cell Research Laboratory at the Murdoch Children's Research Institute. Her current research interest is aimed at extending the use of cord blood for cellular therapies, particularly through clinical grade cord blood derived iPSCs and cord blood for cardiac repair..

Ngaire serves as Chair of the AusCord network of public cord blood banks. She is Vice President of the international Board of Directors for the Foundation for the Accreditation of Cellular Therapies (FACT), is a FACT inspector and serves on various FACT committees. Other board and executive appointments include Non-Executive Director on the Board of the National Stem Cell Foundation of Australia, Chair of the Australian Sickle Cell Advocacy Inc, and a member of the Board of the International Society for Cell & Gene Therapy (ISCT). Ngaire serves on the TGA Advisory Committee on Biologicals and the MCRI Institutional Biosafety Committee.

Ngaire has devoted her career to providing improved therapies for the treatment of cancer, leukaemia and other disorders, and is passionate about the therapeutic application of cellular therapies.

Top Publications

  • Davies, B, Elwood, NJ, Li, S, Cullinane, F, Edwards, GA, Newgreen, DF, Brizard, CP. Human cord blood stem cells enhance neonatal right ventricular function in an ovine model of right ventricular training.. Ann Thorac Surg 89(2) : 585 -593.e4 2010
    view publication
  • Buck, NE, Cheah, DMY, Elwood, NJ, Wright, PFA, Allen, KJ. Correction of copper metabolism is not sustained long term in Wilson's disease mice post bone marrow transplantation.. Hepatol Int 2(1) : 72 -79 2008
    view publication
  • Rothacker, J, Ramsay, RG, Ciznadija, D, Gras, E, Neylon, CB, Elwood, NJ, Bouchier-Hayes, D, Gibbs, P, Rosenthal, MA, Nice, EC. A novel magnetic bead-based assay with high sensitivity and selectivity for analysis of telomerase in exfoliated cells from patients with bladder and colon cancer.. Electrophoresis 28(23) : 4435 -4446 2007
    view publication
  • Li, S, Ferguson, MJ, Hawkins, CJ, Smith, C, Elwood, NJ. Human telomerase reverse transcriptase protects hematopoietic progenitor TF-1 cells from death and quiescence induced by cytokine withdrawal.. Leukemia 20(7) : 1270 -1278 2006
    view publication
  • Elwood, NJ, Jiang, X-R, Chiu, C-P, Lebkowski, JS, Smith, CA. Enhanced long-term survival, but no increase in replicative capacity, following retroviral transduction of human cord blood CD34+ cells with human telomerase reverse transcriptase.. Haematologica 89(3) : 377 -378 2004
    view publication

Page 10 of 14